|
|
Cresco Labs Inc
CSE •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 10/30/2026
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeCSE
Market Capitalization322.11 mln
Float346 mln
Earnings Date11/06/2026
Key Fundamentals
EPS-0.53
ROE-26.50
RPS2.47
ROIC7.92
ROA-8.04
Interest Cover1.42
EBITDA, mln17.99
EV / EBITDA62.77
EV / EBIT-19.14
Revenue, mln900
EV / Revenue1.25
Quote Details
Last
0.80
Change
-0.05 (-5.88%)
Open
0.85
Volume
92,616
Turnover
74,093
Average Volume
62,915
Financial Ratios
Pre-Tax Profit Margin-16
Leverage Ratio3.52
Current Ratio1.78
Price / Book0.93
Price / Cash Flow5.23
Price / Free Cash Flow26.57
Debt / Equity1.65
Price / Sales0.40
Financial Strength
Altman Z-Score-1
Piotroski F-Score
2
/ 9
Beneish M-Score-2.93
Price to Intrinsic Value1.04
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
-3.61% |
56
/ 100
 |
| 1 Month |
-11.11% |
70
/ 100
 |
| 2 Months |
-16.67% |
59
/ 100
|
| 6 Months |
-45.95% |
42
/ 100
 |
| 1 Year |
-52.66% |
34
/ 100
 |
|
| |
